Vaxxa Balance Sheet Health
Financial Health criteria checks 4/6
Vaxxa has a total shareholder equity of SEK11.8M and total debt of SEK1.3M, which brings its debt-to-equity ratio to 11.4%. Its total assets and total liabilities are SEK18.3M and SEK6.5M respectively.
Key information
11.4%
Debt to equity ratio
kr1.34m
Debt
Interest coverage ratio | n/a |
Cash | kr4.83m |
Equity | kr11.80m |
Total liabilities | kr6.50m |
Total assets | kr18.30m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VAXXA's short term assets (SEK7.2M) exceed its short term liabilities (SEK5.2M).
Long Term Liabilities: VAXXA's short term assets (SEK7.2M) exceed its long term liabilities (SEK1.3M).
Debt to Equity History and Analysis
Debt Level: VAXXA has more cash than its total debt.
Reducing Debt: VAXXA's debt to equity ratio has increased from 0% to 11.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VAXXA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VAXXA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.7% each year